Pleiotropy of PCSK9: Functions in Extrahepatic Tissues

被引：0
|
作者：
Yusuf Ziya Şener
Lale Tokgözoğlu
机构：
[1] Beypazarı State Hospital,Cardiology Department
[2] Hacettepe University Faculty of Medicine,Cardiology Department
来源：
Current Cardiology Reports | 2023年 / 25卷
关键词：
PCSK9; Heart; Kidney; Diabetes; Brain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：979 / 985
页数：6
相关论文
共 50 条
  • [21] Safety of PCSK9 inhibitors
    Grzesk, Grzegorz
    Dorota, Bednarska
    Wolowiec, Lukasz
    Wolowiec, Anna
    Osiak, Joanna
    Kozakiewicz, Mariusz
    Banach, Joanna
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [22] Hypercholesterolemia: The role of PCSK9
    Melendez, Quantil M.
    Krishnaji, Sreevidhya T.
    Wooten, Catherine J.
    Lopez, Dayami
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2017, 625 : 39 - 53
  • [23] Heart to heart with PCSK9
    Chemello, Kevin
    Jaafar, Ali K.
    Lambert, Gilles
    EUROPEAN HEART JOURNAL, 2021, 42 (32) : 3091 - 3093
  • [24] Targeting PCSK9 for Hypercholesterolemia
    Norata, Giuseppe Danilo
    Tibolla, Gianpaolo
    Catapano, Alberico Luigi
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 273 - 293
  • [25] PCSK9 Mediates Atherogenesis
    Sun, Hua
    Krauss, Ronald M.
    Teng, Ba-bie
    CIRCULATION, 2016, 134
  • [26] PCSK9 and its modulation
    Cui, Chuan-Jue
    Li, Sha
    Li, Jian-Jun
    CLINICA CHIMICA ACTA, 2015, 440 : 79 - 86
  • [27] PCSK9: An enigmatic protease
    Lopez, Dayami
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2008, 1781 (04): : 184 - 191
  • [28] Access to PCSK9 Inhibitors
    Baum, Seth J.
    Lepor, Norman E.
    Robinson, Jennifer G.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 : S47 - S50
  • [29] Oral PCSK9 Inhibitors
    Anandita Agarwala
    Ramsha Asim
    Christie M. Ballantyne
    Current Atherosclerosis Reports, 2024, 26 : 147 - 152
  • [30] PCSK9 inhibition in PAD
    Karina Huynh
    Nature Reviews Cardiology, 2018, 15 : 4 - 5
12345